retatrutide phase 2 trial type 2 diabetes weight loss 🚨 BREAKING: Shows “Bariatric-Level” in 3 New Phase 3 TRIUMPH-1 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most Retatrutide: A Promising Option for

Interestingly, hair loss concerns are reported anecdotally at higher doses, likely related to the rapid weight loss rather than a direct drug effect

As of 2026, Retatrutide (LY3437943) is investigational in Phase 3 development and not approved by any regulator

While some telehealth companies have completely ceased offering tirzepatide and semaglutide, others have adjusted their offerings so that they are either in oral formats (like dissolving tablets) that are different than injectables, in custom dosages, or sold with additives like vitamin B

Ive seen a steady 12 lb weight loss per week, and my post-meal crashes are gone

The Bigger Picture Side effects are a normal part of starting GLP-1 therapy for most people